SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Samrat Pharmachem informs about newspaper publication

24 Dec 2020 Evaluate

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, Samrat Pharmachem has informed that it has furnished the copy of newspaper publication of Notice of 28th AGM, Book Closure & E-voting information. The Notice was published in the newspapers ‘Indian Express (In English, Ahmedabad Edition) and Vadodara Samachar (In Gujarati, Vadodara Edition)’ on December 24, 2020.

The above information is a part of company’s filings submitted to BSE.


Samrat Pharmachem Share Price

261.35 24.85 (10.51%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: